MedTrace Logo

Impact of Administration of Esmolol on Nociception Level-guided Control of Nociception.

NCT06291363 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2024-07-16

No results posted yet for this study

Summary

This study aims to evaluate esmolol's perfusion impact during induction and maintenance of general anesthesia, using Nociception-Level-guided control of nociception, in adult patients undergoing laparoscopic and lower abdominal surgery, on intraoperative remifentanil consumption and postoperative pain in the Post-Anesthesia Care Unit.

Conditions

  • Opioid Use, Unspecified
  • Anesthesia
  • Nociceptive Pain

Interventions

DRUG

Esmolol Hydrochloride

Patients in the experimental group will receive esmolol during general anesthesia

DRUG

Saline

Patients in the standard of care group will receive saline as placebo during general anesthesia

Sponsors & Collaborators

  • Ciusss de L'Est de l'Île de Montréal

    lead OTHER

Principal Investigators

  • Pascal Laferrière-Langlois · Ciusss de L'Est de l'Île de Montréal

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-04-16
Primary Completion
2025-03-03
Completion
2025-03-04

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06291363 on ClinicalTrials.gov